Sickle Cell Disease Nursing Guide 2026
⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.
Part of the ICU Emergencies Hub — browse every related guide in one place.
This article was created with AI assistance.
Vaso-occlusive pain crisis management, acute chest syndrome recognition, stroke, hydroxyurea, transfusion, and the nursing care priorities that every nurse seeing sickle cell patients must know.
1. Pathophysiology in Brief
Sickle cell disease (SCD) is an autosomal recessive disorder causing production of hemoglobin S (HbS) instead of normal HbA. Under low oxygen conditions (hypoxia, dehydration, cold, infection, stress), HbS polymerizes → red blood cells deform into a crescent (sickle) shape → cells become rigid and adhesive → microvascular occlusion + hemolysis.
The two main pathological mechanisms:
- Vascular occlusion: Sickled RBCs block small vessels → ischemia and pain in affected tissue
- Hemolysis: Sickled cells are fragile and destroyed prematurely (RBC lifespan 10–20 days vs normal 120 days) → chronic hemolytic anemia (baseline Hgb 6–10 g/dL)
2. Common Triggers for Crisis
- Infection (most common precipitant — especially encapsulated organisms in asplenic patients)
- Dehydration
- Cold temperatures / weather changes
- Hypoxia (altitude, respiratory illness)
- Stress (physical or emotional)
- Alcohol use
- Menstruation
3. Types of Sickle Cell Crises
Vaso-Occlusive Crisis (VOC) — Most Common (Pain Crisis)
Microvascular occlusion causes severe ischemic pain in bones (most commonly: back, chest, extremities, abdomen). Extremely painful — patients often have years of experience with their own pain pattern.
VOC pain management priorities:
- Assess pain with standard pain scale (NRS 0–10) — take patient's report seriously; do NOT undertreat
- Administer opioids promptly — IV morphine, hydromorphone, or fentanyl. Follow institutional weight-based protocol.
- Assess pain and vitals 30–60 min after every opioid dose; titrate PRN
- NSAIDs (ketorolac) as adjunct analgesic if no contraindication (renal function)
- Heating pads to affected joints (cold worsens sickling)
- IV hydration (NS or D5½NS) — corrects dehydration + reduces sickling; caution not to fluid overload in ACS
- Supplemental O2 if SpO2 <95%
- Incentive spirometry q2h to prevent atelectasis and ACS
- Oral hydration encouraged; warm beverages
Sickle cell patients are often undertreated for pain due to opioid bias. Treat pain aggressively and reassess frequently. Many patients require doses significantly higher than typical because of opioid tolerance from chronic use.
Acute Chest Syndrome (ACS) — Most Common Cause of Death in Adults
Acute Chest Syndrome: A new pulmonary infiltrate + respiratory symptoms (chest pain, cough, fever, SpO2 drop, tachypnea) in a sickle cell patient. Most dangerous complication — progresses rapidly.
Treatment:
- Supplemental oxygen — target SpO2 ≥95%
- Incentive spirometry (most important prevention)
- Antibiotics: ceftriaxone + azithromycin (covers typical + atypical organisms)
- Bronchodilators (albuterol) if wheeze or history of reactive airway
- Simple transfusion (Hgb rise 2–3 g/dL) for mild-moderate ACS
- Exchange transfusion for severe ACS (SpO2 <90% despite O2, rapid progression) — replaces sickled cells with donor RBCs; target HbS <30%
- Analgesics (but avoid oversedation — respiratory depression worsens hypoxia)
- AVOID: fluid overload (worsens pulmonary infiltrates), hyperoxygenation (causes reflex hypoventilation)
Splenic Sequestration Crisis
Massive trapping of blood in spleen → splenomegaly + acute anemia (Hgb drops by ≥2 g/dL) → hypovolemic shock. Most common in young children (before spleen autoinfarcts in adults). Treatment: IV fluids + blood transfusion. AVOID: palpating the spleen repeatedly (can release sequestered blood causing rebound hypervolemia).
Aplastic Crisis
Temporary suppression of RBC production — usually from parvovirus B19 infection. Sudden severe anemia + reticulocytopenia (reticulocytes <1%). Treatment: supportive + RBC transfusion.
Stroke
Ischemic stroke most common in children; hemorrhagic more common in adults. Transcranial Doppler (TCD) screens for elevated MCA velocity (risk of stroke); prophylactic transfusion program if velocity elevated. Treatment of acute ischemic stroke: exchange transfusion (not standard tPA — thrombolytics less studied in SCD; exchange transfusion preferred).
Priapism
Prolonged painful erection from obstruction of venous outflow. Medical emergency — permanent erectile dysfunction if >4 hours. Treatment: IV hydration, analgesics, urologic consultation for aspiration/irrigation. Exchange transfusion if persists. Prevention: hydroxyurea.
4. Chronic Complications
| System | Complications |
|---|
| Bone | Avascular necrosis (femoral head most common), osteomyelitis (Salmonella most common — note: unlike general population where Staph is #1) |
| Heart | Cardiomegaly (compensatory for chronic anemia), pulmonary hypertension |
| Lungs | Recurrent ACS → pulmonary fibrosis, restrictive lung disease |
| Kidneys | Sickle cell nephropathy, isosthenuria (inability to concentrate urine → nocturia, enuresis), hematuria, end-stage renal disease |
| Eyes | Proliferative sickle retinopathy, retinal detachment, vitreous hemorrhage |
| Spleen | Autosplenectomy (functional asplenia by adulthood) → susceptibility to encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis) |
| Liver/Gallbladder | Cholelithiasis (pigmented gallstones from chronic hemolysis) — most common cause of RUQ pain in SCD after VOC |
5. Medications
Hydroxyurea (First-Line Disease-Modifying Therapy)
Hydroxyurea — how it works and what nurses need to know:
- Increases fetal hemoglobin (HbF) production → HbF inhibits HbS polymerization → fewer sickled cells, fewer crises
- Reduces crisis frequency by ~50%; reduces ACS; reduces need for transfusions; improves survival
- Monitor: CBC q4 weeks (myelosuppression — ANC <2,000 or platelets <80,000 → hold and notify); kidney function; LFTs
- Side effects: myelosuppression, skin hyperpigmentation, nail changes, leg ulcers
- Teratogenic — effective contraception required; men should also use contraception (affects sperm)
- Takes 3–6 months to see full benefit
Other Medications
- Folic acid 1 mg/day: Compensates for high RBC turnover (folate depleted by chronic hemolysis)
- Voxelotor (Oxbryta): Inhibits HbS polymerization; increases Hgb levels
- Crizanlizumab (Adakveo): Anti-P-selectin monoclonal antibody; reduces vascular occlusion; decreases VOC frequency
- L-glutamine (Endari): Reduces oxidative damage to RBCs; decreases VOC frequency
- Penicillin prophylaxis: Children with SCD take daily penicillin until at least age 5 (functional asplenia → pneumococcal sepsis risk)
- Vaccinations: Pneumococcal (PCV15/PPSV23), meningococcal (MenACWY + MenB), Hib, annual influenza — all critical in asplenic patients
6. Transfusion in SCD
| Type | Indication | Goal |
|---|
| Simple transfusion | Aplastic crisis, mild-moderate ACS, symptomatic severe anemia | Hgb rise 2–3 g/dL; do NOT raise Hgb >10–11 (increases viscosity → worsens sickling) |
| Exchange transfusion (partial exchange or erythrocytapheresis) | Severe ACS, ischemic stroke, priapism >4 hr, acute intrahepatic cholestasis | Target HbS <30%; removes sickled cells, replaces with normal donor RBCs |
Transfusion complications in SCD: Iron overload (from chronic transfusions) → treat with iron chelation therapy (deferoxamine or deferasirox). Alloimmunization (developing antibodies to donor RBC antigens) — increases crossmatch difficulty; use sickle cell-matched units when possible. Hyperviscosity if Hgb raised too high.
NCLEX High-Yield Sickle Cell Points
- Sickle cell triggers: infection (most common), dehydration, cold, hypoxia, stress
- Pain crisis treatment priority: IV fluids + opioids + incentive spirometry
- Heating pads for VOC — cold worsens sickling
- Acute Chest Syndrome = most common cause of death in adults with SCD
- ACS treatment: O2 + incentive spirometry + antibiotics + transfusion/exchange
- Osteomyelitis in SCD: most common organism = Salmonella (not Staph like general population)
- Asplenic patient vaccinations: pneumococcal, meningococcal, Hib, flu
- Hydroxyurea: increases fetal hemoglobin (HbF); monitor CBC for myelosuppression; teratogenic
- Simple transfusion: do NOT raise Hgb >10–11 g/dL (viscosity risk)
- Aplastic crisis: caused by Parvovirus B19; reticulocytopenia + severe anemia; treat with transfusion
Get the ICU Notebook
Free investing strategies built for nurses. One email per week, no fluff.
Yes, send it free
No spam. Unsubscribe any time.